实体器官移植患者心脏手术结局
本研究纳入2011-2018年接受单纯冠状动脉旁路移植术、单纯瓣膜手术或冠状动脉旁路移植术+瓣膜手术的成人患者,分析其中实体器官移植患者的术后结局。129例(1%)患者有实体器官移植,术后30天死亡率为2%,5年再入院率高达88%,瓣膜手术患者再入院风险显著更高。
要点
- 实体器官移植患者心脏手术30天死亡率低(2%),长期生存良好。
- COPD和充血性心力衰竭与5年死亡率显著相关。
- 5年再入院率88%,瓣膜手术患者再入院风险显著更高。
核心结论
- 实体器官移植患者可安全接受心脏手术,手术死亡率低且长期生存良好。
- 5年再入院常见,瓣膜手术患者再入院风险显著更高。
研究设计与样本
- 回顾性队列研究,纳入2011-2018年在本机构接受单纯CABG、单纯瓣膜或CABG+瓣膜手术的成人患者。
- 共11,190例患者,其中129例(1%)有实体器官移植。
- 移植器官类型:肾84例(65%)、肝27例(21%)、心9例(7%)、肺9例(7%)。
- 队列STS预测死亡风险中位数为2.73(Q1-Q3: 1.67-6.33)。
主要发现
- 30天死亡率为2%(3例)。
- 与5年再入院显著相关的变量包括COPD、透析依赖和CABG同期瓣膜手术。
临床怎么用
- 实体器官移植患者心脏手术围术期风险可接受,但需关注长期再入院风险。
- 合并COPD或充血性心力衰竭的移植患者术后死亡风险更高,应加强随访。
- 瓣膜手术患者再入院风险显著增加,需优化出院管理和随访策略。
局限性
- 单中心回顾性研究,样本量较小(129例移植患者)。
- 仅纳入单纯CABG、单纯瓣膜或CABG+瓣膜手术,未涵盖其他心脏手术类型。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Long-term outcomes after cardiac surgery in solid organ transplant recipients are limited in the contemporary literature. The objective of this study is to evaluate postoperative outcomes in these patients, including variables associated with mortality and readmissions. METHODS: All adults undergoing isolated coronary artery bypass grafting, isolated valve, or coronary artery bypass grafting + valve cardiac surgical procedures from 2011 to 2018 were included in this study. Patients with solid organ transplants undergoing cardiac surgery were studied. Primary outcomes included operative (30-day) and 5-year mortality. RESULTS: A total of 11,190 patients underwent isolated coronary artery bypass grafting, isolated valve, or coronary artery bypass grafting + valve operations at our institution from 2011 to 2018. Of these, 129 patients (1%) had solid organ transplants and underwent isolated coronary artery bypass grafting (n = 84), isolated valve (n = 30), or coronary artery bypass grafting + valve (n = 15). Type of organ transplant included 84 patients (65%) with kidney, 27 patients (21%) with liver, 9 patients (7%) with heart, and 9 patients (7%) with lung transplants. The median Society of Thoracic Surgeons Predicted Risk Of Mortality for the cohort was 2.73 (Q1-Q3: 1.67-6.33). Three patients (2%) had an operative (30-day) mortality. Significant variables associated with 5-year mortality on multivariable Cox regression analysis included chronic obstructive pulmonary disease (hazard ratio, 2.44; 1.01-5.90; P = .048) and congestive heart failure (hazard ratio, 4.45; 1.81-10.9; P = .001). Significant variables associated with 5-year readmissions included chronic obstructive pulmonary disease, dialysis dependence, and concomittant valve surgery with coronary artery bypass grafting. Five-year readmission rate was 88%, and patients with valve operations (± coronary artery bypass grafting) had significantly lower (P = .009) freedom from readmission (6%). CONCLUSIONS: Cardiac surgery can be performed with low operative mortality and good long-term survival in patients with solid organ transplants. Five-year hospital readmissions are common, with significantly more readmissions in patients who had valve procedures.
引用
- Bianco V, Kilic A, Gleason TG, et al. Outcomes in patients with solid organ transplants undergoing cardiac surgery. J Thorac Cardiovasc Surg. 2019. PMID: 31564544. doi:10.1016/j.jtcvs.2019.07.102
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。